News Gallery Careers Contact Us Login
According to public relation of Actover, to produce two drugs Remdesivir and Favipiravir

According to public relation of Actover, to produce two drugs Remdesivir and Favipiravir

According to public relation of Actover, to produce two drugs Remdesivir and Favipiravir, the whole team went to extraordinary length in preclinical stages of development and regulatory approval.According to public relation of Actover, to produce two drugs Remdesivir and Favipiravir, the whole team went to extraordinary length in preclinical stages of development and regulatory approval.


“ As the country began to tiptoe its way out of sanction and COVID 19, the best news is that our teams’ endeavors and hard working finally paid off to produce these drugs based on the world standardization. We hope that after legalizing procedure, these drugs can be released into the market and meet the needs of physicians and health care sectors across multiple treatment settings, said chief executive officer of Actover, Nahale Naraghi.


Needless to say, in Actover, quality and drug efficiency are the first priorities. We hope soon we can release these two pharmaceutical drugs with high clinical efficacy and reasonable prices.


We also want to express our senses of gratitude and appreciations to Actover team to work none-stop on this project.